Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hamm

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2012
Surficial redistribution of fallout ¹³¹iodine in a small temperate catchmentJoshua D Landis, Nathan T Hamm, Carl E Renshaw, et al.
Environmental Health Perspectives|October 3, 2015
A Curated Database of Rodent Uterotrophic BioactivityNicole C Kleinstreuer, Patricia C Ceger, David G Allen, et al.
Toxics|May 26, 2023
Systematic Evaluation of the Application of Zebrafish in Toxicology (SEAZIT): Developing a Data Analysis Pipeline for the Assessment of Developmental Toxicity with an Interlaboratory StudyJui-Hua Hsieh, Sue Nolte, Jon T Hamm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trialFairooz F Kabbinavar, Joseph Schulz, Michael McCleod, et al.
American Journal of Clinical Oncology|October 1, 1994
The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel ProjectE P Mamounas, S Anderson, D L Wickerham, et al.
American Journal of Clinical Oncology|December 1, 1987
A phase II trial of chlorambucil in non-small cell lung cancerP S Gentile, T M Woodcock, M S Blumenreich, et al.
Family Practice|July 6, 2019
Multidisciplinary approach to low-dose CT screening for lung cancer in a metropolitan communityLisa B E Shields, Jessica G Wilkett Barnes, Connie Buckley, et al.
Cancer|May 1, 1993
Long-term intravenous hydroxyurea infusions in patients with advanced cancer. A phase I trialM S Blumenreich, M J Kellihan, U G Joseph, et al.
American Journal of Clinical Oncology|April 1, 1994
Inefficacy of low-dose continuous oral etoposide in non-small cell lung cancerM S Blumenreich, S P Sheth, C L Miller, et al.
Physical Therapy|February 12, 2020
The Correlative Strength of Objective Physical Assessment Against the ECOG Performance Status Assessment in Individuals Diagnosed With CancerSarah E Quinn, Catherine E Crandell, Morgan E Blake, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2012
Surficial redistribution of fallout ¹³¹iodine in a small temperate catchmentJoshua D Landis, Nathan T Hamm, Carl E Renshaw, et al.
Environmental Health Perspectives|October 3, 2015
A Curated Database of Rodent Uterotrophic BioactivityNicole C Kleinstreuer, Patricia C Ceger, David G Allen, et al.
Toxics|May 26, 2023
Systematic Evaluation of the Application of Zebrafish in Toxicology (SEAZIT): Developing a Data Analysis Pipeline for the Assessment of Developmental Toxicity with an Interlaboratory StudyJui-Hua Hsieh, Sue Nolte, Jon T Hamm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trialFairooz F Kabbinavar, Joseph Schulz, Michael McCleod, et al.
American Journal of Clinical Oncology|October 1, 1994
The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel ProjectE P Mamounas, S Anderson, D L Wickerham, et al.
American Journal of Clinical Oncology|December 1, 1987
A phase II trial of chlorambucil in non-small cell lung cancerP S Gentile, T M Woodcock, M S Blumenreich, et al.
Family Practice|July 6, 2019
Multidisciplinary approach to low-dose CT screening for lung cancer in a metropolitan communityLisa B E Shields, Jessica G Wilkett Barnes, Connie Buckley, et al.
Cancer|May 1, 1993
Long-term intravenous hydroxyurea infusions in patients with advanced cancer. A phase I trialM S Blumenreich, M J Kellihan, U G Joseph, et al.
American Journal of Clinical Oncology|April 1, 1994
Inefficacy of low-dose continuous oral etoposide in non-small cell lung cancerM S Blumenreich, S P Sheth, C L Miller, et al.
Physical Therapy|February 12, 2020
The Correlative Strength of Objective Physical Assessment Against the ECOG Performance Status Assessment in Individuals Diagnosed With CancerSarah E Quinn, Catherine E Crandell, Morgan E Blake, et al.
Pageof 5